Patents by Inventor Yu-Shuan Chen

Yu-Shuan Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREVENTION OR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS BY ADMINISTERING GASTRODIN
    Publication number: 20230263813
    Abstract: Provided is a pharmaceutical composition including gastrodin and a use thereof for the prevention or the treatment of amyotrophic lateral sclerosis. The pharmaceutical composition is effective in reducing neuronal axon degeneration and neurofibromin accumulation, improving symptoms of amyotrophic lateral sclerosis and extending life of patients of amyotrophic lateral sclerosis.
    Type: Application
    Filed: September 16, 2022
    Publication date: August 24, 2023
    Inventors: Chia-Yu CHANG, Shinn-Zong LIN, Hsiao-Chien TING, Hui-I YANG, Horng-Jyh HARN, Hong-Lin SU, Ching-Ann LIU, Yu-Shuan CHEN, Tzyy-Wen CHIOU, Tsung-Jung HO
  • TRANSDERMAL DELIVERY DEVICE, METHODS OF USING AND MAKING THE SAME
    Publication number: 20230149678
    Abstract: Provided is a device for transdermal delivery of drugs. The device includes a separable substrate and is loaded with dual drugs based on an interpenetrating polymer network hydrogel. Also provided are methods of making and using the transdermal delivery device.
    Type: Application
    Filed: November 12, 2021
    Publication date: May 18, 2023
    Applicant: BUDDHIST TZU CHI MEDICAL FOUNDATION
    Inventors: Yu-Shuan Chen, Hsieh-Chih Tsai, Chang-Yi Lee, Haile Fentahun Darge, Shinn-Zong Lin, Tzyy-Wen Chiou, Chia-Yu Chang
  • Vero cell-based influenza virus strains and vaccines
    Patent number: 7931906
    Abstract: The present invention relates to isolated influenza virus strains suitable for increased vaccine production for mammals. The influenza virus strains contain at least one modified influenza protein that results in increased production of the influenza virus from a mammalian host cell, such as a vero cell. The present invention also relates to the vaccines produced from the influenza virus strains. The present invention further relates to isolated modified influenza proteins and isolated nucleic acid molecules that encode for the modified influenza proteins.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: April 26, 2011
    Assignee: National Health Research Institutes
    Inventors: Min-Shi Lee, Yu-Shuan Chen, Yu-Fen Tseng, Pele Choi-Sing Chong
  • VERO CELL-BASED INFLUENZA VIRUS STRAINS AND VACCINES
    Publication number: 20090074804
    Abstract: The present invention relates to isolated influenza virus strains suitable for increased vaccine production for mammals. The influenza virus strains contain at least one modified influenza protein that results in increased production of the influenza virus from a mammalian host cell, such as a vero cell. The present invention also relates to the vaccines produced from the influenza virus strains. The present invention further relates to isolated modified influenza proteins and isolated nucleic acid molecules that encode for the modified influenza proteins.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 19, 2009
    Applicant: National Health Research Institute (an institution of Taiwan, R.O.C.)
    Inventors: Min-Shi Lee, Yu Shuan Chen, Yu-Fen Tseng, Pele Choi-Sing Chong